Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07760623

Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension

To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Invstigation center

Vadhana, Bangkok, 10110, Thailand

Location contact

Nathaphong Dejthida, Medical Degree

CONTACT

[email protected]

0819220662

About this study

The study of the first degree, both sides in some of the aortic branch group, the effect and/or cause of systemic arterial hypertension compared to normotension. According to the theory of systemic arterial hypertension, the arterial resistance and high blood volume flow causing systemic arterial hypertension, the cause of arterial resistance and high blood volume flow evaluation may trace back to the possible actual cause of systemic arterial hypertension by backward investigation. Despite the fact that target organ damage is the crucial maneuver of hypertension evaluation, both sides of the common carotid artery, renal artery, and femoral artery may cause systemic arterial hypertension and may imply that feasible to predict the end organ of stroke, ESRD, and amputated-type arterial occlusion, respectively.

This study belongs to 2 questions

  • Can the main aortic branch be evidence of a cause of systemic arterial hypertension following high resistance and/or high fluid flow by theory?
  • Can the main aortic branch be a marker of evidence of endpoint organ damage?

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.
  • Imaging evidence of at least 1 list of
  • Common carotid artery
  • Renal artery
  • Femoral artery

Exclusion criteria

  • Fatal pathology and imaging
  • Pediatric or pregnant participants
  • Small vessel angiogram
  • Intravascular endoscopy
  • Intra-operative estimation

Treatment and study plan

Diameter measurement

Other

Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery

Velocity

Other

Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)

Primary outcomes

  1. Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.

    Time frame: 1 years

    Radiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients.

Secondary outcomes

  1. Common Carotid Artery Function

    Time frame: 1 year

    Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Common Carotid Artery

  2. Renal Artery Function

    Time frame: 1 year

    Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Renal Artery

  3. Femoral Artery Function

    Time frame: 1 year

    Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Femoral Artery

Other outcomes

  1. All-cause mortality outcomes

    Time frame: 1 year

    Incidence of mortality rate (case per 1,000 person-year) of hypertensive participants were underwent measurement the diameter one side of one of common carotid artery and/or renal artery and/or femoral artery

Study contacts

Contact information is provided by the study sponsor or research team.

Nathaphong Dejthida, Medical Degree

CONTACT

[email protected]

+66819220662

Sponsors and collaborators

Lead sponsor

DejthidaNathaphong

Other

Registry information

Official study title

Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)

Acronym: CRF Survey

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Aug 12, 2026
Registry last updated
Aug 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.